| Year |
Title |
Altmetric |
| 2019
|
Management of Gastrointestinal Neuroendocrine Tumors.
Clinical Medicine Insights : Endocrinology and Diabetes.
12.
2019
|
|
| 2018
|
Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.
Oncotarget.
9:37662-37675.
2018
|
|
| 2018
|
Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes.
Molecular Brain.
11:64.
2018
|
|
| 2018
|
Cdk5 Contributes to Huntington’s Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.
Molecular Neurobiology.
55:6250-6268.
2018
|
|
| 2018
|
Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.
Theranostics.
8:1131-1145.
2018
|
|
| 2016
|
The Emerging Role of Cdk5 in Cancer.
Trends in Cancer.
2:606-618.
2016
|
|
| 2016
|
Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum.
Scientific Reports.
6.
2016
|
|
| 2016
|
An adenosine-mediated glial-neuronal circuit for homeostatic sleep.
Journal of Neuroscience.
36:3709-3721.
2016
|
|
| 2016
|
Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.
Oncotarget.
7:6088-6104.
2016
|
|
| 2015
|
The role of ventral striatal cAMP signaling in stress-induced behaviors.
Nature Neuroscience.
18:1094-1100.
2015
|
|
| 2015
|
Regulation of ERK kinase by MEK1 kinase inhibition in the brain.
Journal of Biological Chemistry.
290:16319-16329.
2015
|
|
| 2015
|
Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.
Nature Communications.
6.
2015
|
|
| 2015
|
Cdk5 regulates the development of the lymphatic vasculature via phosphorylation of the transcription factor Foxc2.
Vasomed.
27:195-196.
2015
|
|
| 2015
|
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.
Oncotarget.
6:12080-12093.
2015
|
|
| 2014
|
Memory enhancement by targeting Cdk5 regulation of NR2B.
Neuron.
81:1070-1083.
2014
|
|
| 2014
|
P38α regulates SERCA2a function.
Journal of Molecular and Cellular Cardiology.
67:86-93.
2014
|
|
| 2014
|
Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?.
Oncotarget.
5:5-6.
2014
|
|
| 2014
|
Enhancement of neuromuscular dynamics and strength behavior using extremely low magnitude mechanical signals in mice.
Journal of Biomechanics.
47:162-167.
2014
|
|
| 2014
|
Ischemic stroke injury is mediated by aberrant Cdk5.
Journal of Neuroscience.
34:8259-8267.
2014
|
|
| 2013
|
The Role of Cdk5 in Neuroendocrine Thyroid Cancer.
Cancer Cell.
24:499-511.
2013
|
|
| 2013
|
Early Postnatal In Vivo Gliogenesis From Nestin-Lineage Progenitors Requires Cdk5.
PLoS ONE.
8.
2013
|
|
| 2013
|
P39, the primary activator for cyclin-dependent kinase 5 (CDK5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
Journal of Biological Chemistry.
288:18047-18057.
2013
|
|
| 2013
|
Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.
Developmental Biology.
378:94-106.
2013
|
|
| 2012
|
A mutation in CLOCK leads to altered dopamine receptor function.
Journal of Neurochemistry.
123:124-134.
2012
|
|
| 2012
|
Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
Psychopharmacology.
219:1065-1079.
2012
|
|
| 2011
|
Striatal signal transduction and drug addiction.
Frontiers in Neuroanatomy.
2011
|
|
| 2011
|
Is CREB the angry bird that releases memory in alzheimer's.
Neuropsychopharmacology.
36:2153-2154.
2011
|
|
| 2011
|
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum.
Journal of Neurochemistry.
119:303-313.
2011
|
|
| 2011
|
The role of Cdk5 in cognition and neuropsychiatric and neurological pathology.
Brain Research Bulletin.
85:9-13.
2011
|
|
| 2011
|
Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart.
Circulation Research.
108:437-445.
2011
|
|
| 2010
|
Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.
Biological Psychiatry.
68:1163-1171.
2010
|
|
| 2010
|
Cognition enhancement strategies.
Journal of Neuroscience.
30:14987-14992.
2010
|
|
| 2009
|
Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.
Journal of Neuroscience.
29:9330-9343.
2009
|
|
| 2009
|
Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5.
PLoS ONE.
4.
2009
|
|
| 2008
|
Cdk5 is essential for adult hippocampal neurogenesis.
Proceedings of the National Academy of Sciences.
105:18567-18571.
2008
|
|
| 2008
|
Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology.
Proceedings of the National Academy of Sciences.
105:18561-18566.
2008
|
|
| 2008
|
Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.
European Journal of Pharmacology.
581:270-275.
2008
|
|
| 2007
|
Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability.
Journal of Neuroscience.
27:12967-12976.
2007
|
|
| 2007
|
Differential regulation of the Cdk5-dependent phosphorylation sites of inhibitor-1 and DARPP-32 by depolarization.
Journal of Neurochemistry.
103:1582-1593.
2007
|
|
| 2007
|
Alternative roles for Cdk5 in learning and synaptic plasticity.
Biotechnology Journal.
2:941-948.
2007
|
|
| 2007
|
Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation.
Nature Neuroscience.
10:880-886.
2007
|
|
| 2007
|
Regulation of protein phosphatase inhibitor-1 by cyclin-dependent kinase 5.
Journal of Biological Chemistry.
282:16511-16520.
2007
|
|
| 2007
|
Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine.
Proceedings of the National Academy of Sciences.
104:4147-4152.
2007
|
|
| 2007
|
Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.
Brain Research.
1129:1-14.
2007
|
|
| 2007
|
Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.
Journal of Biological Chemistry.
282:1687-1694.
2007
|
|
| 2006
|
Identification of pyruvate kinase as an antigen associated with Tourette syndrome.
Journal of Neuroimmunology.
181:165-176.
2006
|
|
| 2006
|
Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain.
Journal of Neurochemistry.
99:237-250.
2006
|
|
| 2006
|
Phosphorylation of protein phosphatase inhibitor-1 by protein kinase C.
Journal of Biological Chemistry.
281:24322-24335.
2006
|
|
| 2005
|
Impairment of hippocampal long-term depression and defective spatial learning and memory in p35-/- mice.
Journal of Neurochemistry.
94:917-925.
2005
|
|
| 2005
|
Decoding Dopamine Signaling.
Cell.
122:153-155.
2005
|
|
| 2005
|
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability.
Journal of Neurochemistry.
93:502-512.
2005
|
|
| 2005
|
The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.
Journal of Neuroscience.
25:2933-2940.
2005
|
|
| 2004
|
Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.
Journal of Neurochemistry.
91:374-384.
2004
|
|
| 2004
|
Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation.
European Journal of Biochemistry.
271:3547-3555.
2004
|
|
| 2004
|
PKC-α regulates cardiac contractility and propensity toward heart failure.
Nature Medicine.
10:248-254.
2004
|
|
| 2004
|
Protein kinases talk to lipid phosphatases at the synapse.
Proceedings of the National Academy of Sciences.
101:1112-1113.
2004
|
|
| 2004
|
Role of Cdk5 in drug abuse and plasticity.
Annals of the New York Academy of Sciences.
1025:335-344.
2004
|
|
| 2003
|
Role of Cdk5 in neuronal signaling, plasticity, and drug abuse.
Neurosignals.
12:191-199.
2003
|
|
| 2003
|
Cdk5 and the mystery of synaptic vesicle endocytosis.
Journal of Cell Biology.
163:697-699.
2003
|
|
| 2003
|
Erratum: Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5 (Neuroscience 116: 1 (19-22) PII: S0306452202005602).
Neuroscience.
119:619.
2003
|
|
| 2003
|
Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.
Journal of Neuroscience.
23:1189-1197.
2003
|
|
| 2003
|
Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5.
Neuroscience.
116:19-22.
2003
|
|
| 2002
|
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine.
Nature.
418:774-778.
2002
|
|
| 2002
|
Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: Distinct roles of calcineurin and protein phosphatase-2A.
Journal of Neurochemistry.
81:832-841.
2002
|
|
| 2002
|
Roscovitine: A novel regulator of P/Q-type calcium channels and transmitter release in central neurons.
Journal of Physiology.
540:761-770.
2002
|
|
| 2001
|
Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.
Proceedings of the National Academy of Sciences.
98:11062-11068.
2001
|
|
| 2001
|
Phosphorylation of Protein Phosphatase Inhibitor-1 by Cdk5.
Journal of Biological Chemistry.
276:14490-14497.
2001
|
|
| 2001
|
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.
Nature.
410:376-380.
2001
|
|
| 2001
|
Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?.
Journal of Biological Chemistry.
276:251-260.
2001
|
|
| 2000
|
Amplification of dopaminergic signaling by a positive feedback loop.
Proceedings of the National Academy of Sciences.
97:12840-12845.
2000
|
|
| 2000
|
Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.
Neuropharmacology.
39:1637-1644.
2000
|
|
| 2000
|
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
Proceedings of the National Academy of Sciences.
97:6809-6814.
2000
|
|
| 2000
|
Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25.
European Journal of Biochemistry.
267:5983-5994.
2000
|
|
| 1999
|
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
Nature.
402:669-671.
1999
|
|
| 1995
|
The Human Poliovirus Receptor: Receptor‐Virus Interaction and Parameters of Disease Specificity.
Annals of the New York Academy of Sciences.
753:19-36.
1995
|
|
| 1994
|
The human poliovirus receptor alpha is a serine phosphoprotein.
Journal of Virology.
68:6111-6115.
1994
|
|
| 1994
|
Interaction of Poliovirus with its Cell Surface Binding Site.
Virology.
201:107-115.
1994
|
|
| 1994
|
Molecular Characterization of the Cellular Receptor for Poliovirus.
Virology.
199:105-113.
1994
|
|
| 1994
|
Cleavage site of the poliovirus receptor signal sequence.
Journal of General Virology.
75:1875-1881.
1994
|
|
| 1990
|
Functional analysis of the modes of anion transport in neutrophils and HL-60 cells.
Annual Review of Physiology.
52:381-397.
1990
|
|
| 1987
|
The capsid polypeptides of the 190S virus of Helminthosporium victoriae..
Journal of General Virology.
68.
1987
|
|
